ESTA
Establishment Labs Holdings Inc.
NASDAQ · CRHealthcareMedical - Devices
$93.42+0.91%
Price as of Jul 20, 2026
ESTA financials
Establishment Labs Holdings Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $211.1M | $166.0M | $165.2M | $161.7M |
| Cost of revenue | $64.8M | $56.5M | $58.2M | $55.1M |
| Gross profit | $146.3M | $109.5M | $107.0M | $106.6M |
| Operating expenses | $185.3M | $159.5M | $172.0M | $146.3M |
| Operating income | -$39.0M | -$50.0M | -$65.0M | -$39.7M |
| Net income | -$51.1M | -$84.6M | -$78.5M | -$75.2M |
| EBITDA | -$22.3M | -$56.2M | -$58.3M | -$56.9M |
| Basic EPS | $-1.72 | $-3.00 | $-3.07 | $-3.08 |
| Diluted EPS | $-1.72 | $-3.00 | $-3.07 | $-3.08 |
| Balance sheet | ||||
| Cash & equivalents | $75.6M | $90.3M | $40.0M | $66.4M |
| Total assets | $357.2M | $346.8M | $268.6M | $211.1M |
| Total liabilities | $333.6M | $293.7M | $250.2M | $219.2M |
| Stockholders’ equity | $23.5M | $53.1M | $18.4M | -$8.2M |
| Total debt | $264.5M | $225.3M | $192.2M | $179.3M |
| Net debt | $188.9M | $134.9M | $152.2M | $113.0M |
| Cash flow | ||||
| Operating cash flow | -$50.9M | -$58.5M | -$88.5M | -$52.2M |
| Capital expenditure | -$6.7M | -$15.6M | -$24.5M | -$34.3M |
| Free cash flow | -$57.6M | -$74.1M | -$113.1M | -$86.4M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |